Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Ex-AstraZeneca chief forfeits up to £3.5M in exit pay
Fierce Pharma
Mon, 07/16/12 - 07:36 pm
executive pay
AstraZeneca
David Brennan
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Fri, 07/13/12 - 01:23 pm
GSK
Amylin
AstraZeneca
Merck
Novartis
Pfizer
The Challenges in Staying #1 in Big Pharma
Forbes
Fri, 07/13/12 - 01:22 pm
Merck
Novartis
Pfizer
AstraZeneca
AstraZeneca acquires neuroscience assets from Link Medicine
Yahoo/Fly on the Wall
Thu, 07/12/12 - 12:34 pm
Link Medicine
AstraZeneca
M&A
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Novartis: Buy Before The Bullish Rally
Seeking Alpha
Mon, 07/9/12 - 10:40 am
Novartis
Pfizer
JNJ
AstraZeneca
Amylin Deal Signals Diabetes Space is Hot
Motley Fool
Fri, 07/6/12 - 07:34 pm
diabetes
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
Seven pharma companies partner with Gates Foundation to speed TB drug discovery
Yahoo/Fly on the Wall
Fri, 07/6/12 - 12:45 pm
tuberculosis
Bill Gates
Abbott Laboratories
AstraZeneca
Bayer
Eli Lilly
GSK
Merck
Sanofi
Big Pharma’s Big Fines
ProPublica.org
Thu, 07/5/12 - 05:16 pm
fines
whistleblower lawsuits
Eli Lilly
Pfizer
AstraZeneca
Merck
Abbott Laboratories
GSK
Expert On The Amylin Purchase: 'I Hate This Deal'
Forbes
Tue, 07/3/12 - 01:07 pm
Amylin
Bristol-Myers Squibb
M&A
AstraZeneca
Today's Bio Pharma Buyout News And Watch List
Seeking Alpha
Tue, 07/3/12 - 11:38 am
Amylin
AstraZeneca
Obagi Medical Products
Eli Lilly
GSK
Bristol-Myers Squibb
AstraZeneca hungry to refill medicine cabinet
Yahoo/Reuters
Sat, 06/30/12 - 03:55 pm
AstraZeneca
Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb’s Acquisition of Amylin Pharmaceuticals
Yahoo/BusinessWire
Sat, 06/30/12 - 03:28 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
diabetes
Merck's $303 Million Ambryx Deal Great For Investors
Seeking Alpha
Thu, 06/28/12 - 06:03 pm
Merck
Ambryx
AstraZeneca
GSK
Novartis
Pfizer
Palatin
AstraZeneca Set To Gain From New Asthma Drug
Seeking Alpha
Thu, 06/28/12 - 10:31 am
asthma
AstraZeneca
Rigel
JAK inhibitors
Amgen
GSK
JNJ
Eli Lilly
Merck
R256
Merck to keep recording income from Astra drugs
Reuters
Wed, 06/27/12 - 10:13 am
Merck
AstraZeneca
Nexium
Prilosec
Novartis, four others weigh Amylin final bids: sources
Reuters
Tue, 06/26/12 - 01:26 pm
Novartis
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
Merck
Sanofi
Who Got The Most Buzz At The Noisy BIO Show…
Pharmalot
Sun, 06/24/12 - 11:43 am
Sanofi
AstraZeneca
Pfizer
GSK
Eli Lilly
Johnson & Johnson: Charges Could Damage Stock
Seeking Alpha
Fri, 06/22/12 - 10:27 am
JNJ
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Eli Lilly: New Drug Shows Strong Potential
Seeking Alpha
Fri, 06/22/12 - 09:28 am
Eli Lilly
Incyte
baricitinib
Merck
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
rheumatoid arthritis
Pages
« first
‹ previous
…
122
123
124
125
126
127
128
129
130
…
next ›
last »